China Pharmaceutical University, Hefei Yigong Medicine describe new colchicine derivatives Sep. 20, 2018
Results of a first-in-human study of the JAK 1 inhibitor PF-04965842 in healthy subjects Sep. 13, 2018
Sareum selects SDC-1801 from TYK2 inhibitor program for advancement in autoimmune diseases Sep. 10, 2018
RSS